Comerica Bank
NRIX icon

Comerica Bank’s Nurix Therapeutics NRIX Stock Holding History

Comerica Bank’s Portfolio NRIX Stock Details NRIX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$1.02K Hold
54
– – ﹤0.01% 3582
2025
Q3 		$499 Buy
+54
New +$561 ﹤0.01% 3633
2024
Q2 		– Sell
-96
Closed -$1.42K – 3780
2024
Q1 		$1.42K Hold
96
– – ﹤0.01% 3586
2023
Q4 		$994 Sell
96
-163
-63% -$1.12K ﹤0.01% 3622
2023
Q3 		$2.04K Buy
+259
New +$2.37K ﹤0.01% 3565

Other funds holding NRIX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Comerica Bank's NRIX Position: Q4 2025 in Review

Comerica Bank held its Nurix Therapeutics (NRIX) position steady in Q4 2025 at 54 shares worth $1.02K. The position accounts for ﹤0.01% of the portfolio, ranked #3582.

Comerica Bank first reported a position in NRIX in Q3 2023 and has held it in 5 quarters since. The position peaked at $2.04K in Q3 2023. 182 funds tracked by Wall St. Rank hold NRIX as of Q4 2025.

  • Comerica Bank held 54 shares of Nurix Therapeutics worth $1.02K as of Q4 2025.
  • Comerica Bank left its Nurix Therapeutics share count unchanged in Q4 2025.
  • Nurix Therapeutics made up ﹤0.01% of Comerica Bank's portfolio in Q4 2025, its #3582 holding.
  • Comerica Bank first reported a position in Nurix Therapeutics in Q3 2023 and has held it in 5 quarters since.
  • Comerica Bank's Nurix Therapeutics position peaked at $2.04K in Q3 2023.
  • 182 funds tracked by Wall St. Rank held Nurix Therapeutics as of Q4 2025.

Based on Comerica Bank's 13F filing for Q4 2025, filed 29 Jan 2026.